wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q37604501-5ADAE123-B553-453D-86B7-526E359C64FD
Q37604501-5ADAE123-B553-453D-86B7-526E359C64FD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37604501-5ADAE123-B553-453D-86B7-526E359C64FD
Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study.
P953
Q37604501-5ADAE123-B553-453D-86B7-526E359C64FD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37604501-5ADAE123-B553-453D-86B7-526E359C64FD
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e8eecfe2d4884d60b98359c7a299c6a5d7e32b3b
P3274
White Rose Research Online
P3831
published version
P953
107092